Immuno-oncology company Affimed to be delisted from Nasdaq after insolvency filing

Posted on by wpadmin
Finance stock price list with business district city building background.Stock exchange market and investment. Bank. Cyrptocurrency. 3d illustration

UniqueMotionGraphics

  • Clinical-stage immuno-oncology company Affimed N.V (NASDAQ:AFMD) received a written notice from the staff of the Nasdaq notifying the company that, in accordance with Nasdaq listing rule.
  • The company’s shares will be suspended at the opening of business on May

Leave a Reply

Your email address will not be published. Required fields are marked *